← Eichor
Study identifier: NCT05985447 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Menopause Related Influences on Leukocyte Distribution, Monocyte Function and Platelet Reactivity

Condition: Arteriosclerosis · Acute Myocardial Infarction · Cardiovascular Events  ·  Sponsor: Heinrich-Heine University, Duesseldorf

PhaseN/A
Planned participants180
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Women and men show marked differences in cardiovascular risk profile and outcome. Women experience fewer cardiovascular events than men before menopause, but this relationship seems to reverse at menopause. These disparities are probably due to hormonal factors, especially the female sex hormone estrogen seems to have a protective influence on the development of atherosclerotic plaques premenopausal. The underlying mechanisms of the effect of estrogens on the vessel wall are still insufficiently investigated. In this study, menopause related effects on leukocyte distribution and function as well on platelets and their aggregational response will be evaluated.

This description comes directly from the study's public registry record.

Talk to the study team

Lisa Dannenberg, MD  ·  +492118105315  ·  lisa.dannenberg@med.uni-duesseldorf.de

Always discuss trial participation with your own doctor first.

Locations (1)

University-Hospital Düsseldorf Division of Cardiology, Pulmonary Disease and Vascular MedicineDüsseldorf, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05985447